Vaccines
Multiple series of media products have been designed and marketed for large-scale and high-density suspension culture of common-used cell types in the field of vaccines (such as insect cells, CHO cells, 293 cells, Vero cells, hybridoma cells, MDCK cells, BHK cells, etc.), covering a wide range of vaccine production lines.
The performance of BioEngine medium products stands out among competitors, including top global brands. With remarkable market recognition, our products have served more than 100 vaccine projects, and have been applied to pilot development and industrialization of many vaccine manufacturers in China.

Serving
Applied to human vaccine and animal vaccine projects
Mainly serum-free suspension culture system, successfully applied to 6000 liter scale
Help customers significantly improve production efficiency and reduce costs
*Including human vaccine and animal vaccine projects.
The statistical data as of June 2022.

Typical Cases
| No. | Update | Vaccine | Culture method | Features |
|---|---|---|---|---|
| 01 | Marketed | Avian influenza | Dilution | 6-8 times increase in titer. Free from chick embryo |
| 02 | Marketed | Foot-and-mouth disease |
High-density cell culture with medium exchange process |
The first foot-and-mouth disease vaccine production line using high-density culture technology |
| 03 | BLA | Rabies virus | Perfusion |
The first rabies vaccine production line in serum-free condition in China |
| 04 | Pre-IND | Human influenza | Dilution |
The first influenza vaccine production line in serum-free suspension condition in China |
Recommended Products







